Bone Biologics Corp (NASDAQ: BBLG)
$1.2700
+0.0200 ( +1.60% ) 0.0K
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Market Data
Open
$1.2700
Previous close
$1.2500
Volume
0.0K
Market cap
$3.08M
Day range
$1.2500 - $1.2500
52 week range
$0.8000 - $10.5600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 57 | Aug 09, 2024 |
ars | Annual reports | 1 | Aug 08, 2024 |
def | Proxies and info statements | 3 | Aug 08, 2024 |
8-k | 8K-related | 19 | Aug 02, 2024 |
8-k | 8K-related | 16 | Jun 20, 2024 |
10-q | Quarterly Reports | 58 | May 14, 2024 |
8-k | 8K-related | 15 | Mar 15, 2024 |
8-k | 8K-related | 23 | Mar 06, 2024 |
8-k | 8K-related | 17 | Mar 01, 2024 |
10-k | Annual reports | 67 | Feb 21, 2024 |